Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › Milwaukee › NPI 1861447179
Physician

Aurora Health Care Metro, INC.

Aurora Health Care Metro, INC. was paid $182.03M by Medicaid between Jan 2018 and Dec 2024, across 928 billing codes. Its largest line is 99283, emergency room visit (moderate) — 7.6% of everything it billed.

33Billing provider infoAURORA HEALTH CARE METRO, INC.
MILWAUKEE, WI 53215
33aNPI1861447179assigned 05/24/2006
33bProvider typeHematology & Oncology Physician
28Total paid$182.03M
24GClaims7,447,014
24DCodes billed928
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Hematology & Oncology Physician providers in Wisconsin

Rank by total paid#1 of 10
Median peer was paid$49K
This provider vs. median3,704×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018992,545$24.57M
20191,057,499$24.83M
2020968,194$23.10M
20211,220,791$28.71M
20221,159,207$27.07M
20231,191,712$29.61M
2024incomplete857,066$24.15M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.6% 184,504 158,337 $13.86M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.6% 172,425 147,199 $12.09M
96361 Intravenous infusion, hydration; each additional hour 6.3% 83,728 66,569 $11.54M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.7% 121,652 100,474 $8.55M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 4.3% 127,585 108,282 $7.91M
80053 Comprehensive metabolic panel 3.0% 302,198 212,125 $5.39M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.8% 154,376 60,378 $5.01M
J9271 Injection, pembrolizumab, 1 mg 2.4% 3,828 2,743 $4.31M
70450 Computed tomography, head or brain; without contrast material 2.0% 46,146 40,370 $3.57M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.8% 43,086 37,563 $3.24M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.5% 32,521 28,979 $2.66M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.3% 25,689 21,083 $2.37M
916 more codes
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.2% 27,886 $2.27M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 375,774 $2.24M
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.2% 54,065 $2.24M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 33,332 $2.20M
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.1% 21,369 $1.96M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.0% 36,036 $1.90M
80048 Basic metabolic panel (calcium, ionized) 1.0% 90,921 $1.85M
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.0% 84,075 $1.84M
84484 <1% 131,308 $1.49M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 14,410 $1.46M
80047 <1% 47,492 $1.32M
71275 Computed tomographic angiography, chest, with contrast material <1% 14,693 $1.29M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 32,259 $1.22M
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 58,031 $1.21M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 26,597 $1.20M
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 14,962 $1.13M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 5,700 $1.12M
83880 <1% 38,368 $1.10M
77386 <1% 8,331 $1.03M
93356 <1% 10,936 $1.02M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 16,851 $1.01M
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 35,199 $1.01M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 24,876 $998K
93798 <1% 15,949 $971K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 26,948 $969K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 26,982 $904K
P9016 Red blood cells, leukocytes reduced, each unit <1% 2,863 $875K
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg <1% 2,836 $858K
84703 <1% 53,832 $814K
97162 <1% 21,796 $797K
84702 <1% 45,583 $785K
93458 <1% 1,796 $783K
99215 Doctor's office visit, returning patient (complex) <1% 19,940 $761K
G0378 Hospital observation service, per hour <1% 44,538 $755K
97161 <1% 19,222 $749K
82962 <1% 96,099 $737K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 4,387 $734K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 4,010 $713K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 8,878 $704K
99214 Doctor's office visit, returning patient (more involved) <1% 22,723 $702K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 12,484 $690K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 2,758 $659K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 5,834 $623K
82077 <1% 28,981 $619K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 3,129 $584K
99213 Doctor's office visit, returning patient (routine) <1% 11,216 $557K
96367 <1% 10,305 $551K
83690 <1% 93,899 $545K
J2505 Injection, pegfilgrastim, 6 mg <1% 902 $540K
83735 <1% 106,760 $521K
49083 <1% 3,540 $521K
96415 <1% 5,963 $509K
77412 <1% 4,863 $504K
93975 <1% 10,823 $497K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 10,589 $491K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 13,052 $484K
78815 Positron emission tomography (PET) for limited area imaging <1% 2,471 $480K
27447 <1% 282 $475K
87086 Culture, bacterial; quantitative colony count, urine <1% 40,990 $469K
72125 Computed tomography, cervical spine; without contrast material <1% 14,952 $469K
93308 <1% 4,171 $467K
76830 Ultrasound, transvaginal <1% 11,265 $460K
64493 <1% 1,881 $459K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 6,650 $458K
86850 <1% 21,995 $446K
64483 <1% 2,457 $445K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 13,721 $431K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 2,608 $417K
77067 Screening mammography, bilateral, including computer-aided detection <1% 13,400 $413K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 14,896 $401K
97597 <1% 8,915 $400K
29580 <1% 7,146 $395K
93321 <1% 4,249 $389K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 5,350 $385K
64494 <1% 2,455 $380K
19083 <1% 1,075 $371K
76642 <1% 9,660 $369K
71046 Radiologic examination, chest; 2 views <1% 45,900 $364K
12001 <1% 3,917 $360K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 9,512 $357K
43235 <1% 1,986 $356K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 1,032 $354K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,412 $352K
70496 <1% 4,019 $351K
81025 <1% 32,435 $348K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 3,412 $336K
70498 <1% 4,277 $329K
84443 Thyroid stimulating hormone (TSH) <1% 27,691 $328K
85610 <1% 66,668 $315K
10060 <1% 3,436 $313K
81003 <1% 65,393 $305K
82803 <1% 16,251 $304K
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility <1% 2,856 $301K
J3380 Injection, vedolizumab, intravenous, 1 mg <1% 306 $296K
97116 <1% 20,254 $296K
93971 <1% 9,536 $288K
70551 Magnetic resonance imaging, brain; without contrast material <1% 4,311 $286K
64636 <1% 1,371 $286K
93351 <1% 2,383 $283K
J2350 Injection, ocrelizumab, 1 mg <1% 98 $273K
90715 <1% 11,037 $273K
P9047 Infusion, albumin (human), 25%, 50 ml <1% 2,971 $272K
97165 <1% 8,289 $271K
96417 <1% 6,177 $270K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 53,767 $269K
90686 <1% 7,467 $266K
62323 <1% 2,049 $261K
Q5117 Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg <1% 639 $259K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 6,967 $257K
12011 <1% 2,808 $256K
64635 <1% 884 $249K
81001 <1% 69,365 $248K
83605 <1% 25,899 $243K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 4,334 $239K
71250 <1% 6,560 $236K
70486 <1% 6,702 $236K
85027 <1% 50,908 $231K
47563 <1% 240 $231K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 16,803 $227K
70491 <1% 2,886 $223K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 2,952 $223K
82565 <1% 11,496 $222K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 10,028 $220K
83036 Hemoglobin; glycosylated (A1C) <1% 21,781 $219K
20610 <1% 2,314 $218K
0240U <1% 6,544 $217K
81513 <1% 2,734 $215K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 5,369 $214K
80061 Lipid panel <1% 18,237 $213K
85379 <1% 24,974 $203K
77063 Screening digital breast tomosynthesis, bilateral <1% 12,196 $202K
52356 <1% 211 $202K
84145 <1% 10,972 $200K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 83,722 $200K
12002 <1% 2,159 $196K
86900 <1% 23,795 $194K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 2,431 $192K
72141 <1% 2,789 $190K
96368 <1% 4,015 $189K
95886 <1% 3,552 $189K
95811 <1% 1,426 $188K
97535 Self-care/home management training, each 15 minutes <1% 15,312 $188K
94729 <1% 7,293 $186K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg <1% 1,014 $183K
96416 <1% 1,607 $180K
J9312 Injection, rituximab, 10 mg <1% 414 $179K
82728 <1% 17,394 $178K
93325 <1% 4,504 $177K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 99,073 $177K
C9600 Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch <1% 137 $177K
93017 <1% 4,901 $177K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 7,917 $175K
78582 <1% 1,155 $175K
36430 <1% 2,470 $174K
94060 <1% 6,200 $172K
93970 <1% 3,855 $171K
97166 <1% 5,827 $170K
J9035 Injection, bevacizumab, 10 mg <1% 465 $159K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,971 $158K
76770 <1% 3,255 $158K
87040 <1% 12,941 $158K
73221 <1% 2,194 $157K
29125 <1% 3,224 $155K
29581 <1% 2,939 $154K
J9299 Injection, nivolumab, 1 mg <1% 253 $152K
47562 <1% 167 $152K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 1,000 $151K
J0897 Injection, denosumab, 1 mg <1% 1,796 $151K
Q5120 Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg <1% 179 $150K
80143 <1% 12,862 $150K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 8,172 $148K
Q5121 Injection, infliximab-axxq, biosimilar, (avsola), 10 mg <1% 515 $148K
80179 <1% 12,594 $146K
87077 <1% 11,933 $142K
77066 Tomosynthesis, mammo <1% 5,583 $142K
77336 <1% 4,760 $140K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 21,699 $140K
J1756 Injection, iron sucrose, 1 mg <1% 16,496 $138K
87481 <1% 2,678 $138K
87210 <1% 15,928 $135K
86832 <1% 1,672 $134K
74174 <1% 1,596 $132K
Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg <1% 297 $132K
Q3014 Telehealth originating site facility fee <1% 8,971 $130K
74183 <1% 1,313 $128K
97113 <1% 2,167 $127K
J9022 Injection, atezolizumab, 10 mg <1% 117 $122K
87641 <1% 3,325 $122K
94660 <1% 2,515 $122K
74170 <1% 1,574 $120K
80076 <1% 13,674 $120K
85730 <1% 24,862 $118K
83970 <1% 4,357 $118K
77065 Tomosynthesis, mammo <1% 5,294 $117K
72100 <1% 14,423 $116K
86833 <1% 1,743 $113K
J1453 Injection, fosaprepitant, 1 mg <1% 4,326 $111K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 3,260 $107K
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg <1% 249 $107K
76801 <1% 9,206 $107K
J9202 Goserelin acetate implant, per 3.6 mg <1% 339 $106K
36561 <1% 249 $106K
89051 <1% 4,392 $106K
87186 <1% 12,862 $106K
93454 <1% 284 $105K
94618 <1% 3,223 $100K
72197 <1% 956 $99K
76536 <1% 2,169 $98K
86480 <1% 1,765 $98K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 4,283 $97K
83550 <1% 15,858 $96K
97035 <1% 7,638 $96K
82330 <1% 5,826 $93K
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units <1% 1,892 $92K
52332 <1% 376 $92K
82607 <1% 8,414 $91K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 164,447 $91K
87070 <1% 7,339 $90K
86803 <1% 6,419 $88K
90935 Hemodialysis procedure with single evaluation by a physician <1% 1,014 $85K
77080 <1% 1,872 $84K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 2,251 $84K
83615 <1% 20,477 $82K
71271 <1% 1,578 $81K
77062 <1% 4,572 $80K
0399T <1% 3,727 $80K
93451 <1% 257 $79K
19318 <1% 35 $77K
29130 <1% 1,738 $77K
64484 <1% 546 $77K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 243 $76K
92523 <1% 827 $76K
83540 <1% 16,425 $76K
84132 <1% 10,094 $73K
82105 <1% 4,044 $71K
82746 <1% 7,158 $71K
87081 <1% 3,511 $70K
80197 <1% 7,051 $69K
92610 <1% 2,148 $69K
97163 <1% 2,129 $69K
93307 <1% 613 $68K
95819 <1% 1,022 $67K
87340 <1% 7,970 $67K
J9305 Injection, pemetrexed, not otherwise specified, 10 mg <1% 121 $65K
73562 <1% 14,785 $65K
86140 <1% 14,042 $64K
87563 <1% 2,586 $64K
74018 <1% 6,203 $64K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 978 $63K
76870 <1% 1,892 $62K
19081 <1% 197 $60K
58558 <1% 93 $58K
82784 <1% 4,224 $58K
77002 <1% 2,365 $57K
36000 <1% 21,441 $57K
77300 <1% 1,342 $56K
58661 <1% 69 $56K
86901 <1% 23,778 $56K
58100 <1% 295 $55K
99201 <1% 958 $55K
72040 <1% 3,404 $55K
J2469 Injection, palonosetron hcl, 25 mcg <1% 3,721 $55K
77061 <1% 3,701 $54K
87522 Neg quan hep c or qual rna <1% 1,345 $54K
73030 <1% 12,127 $53K
94726 <1% 6,600 $53K
72110 <1% 2,318 $52K
82550 <1% 10,121 $52K
10160 <1% 536 $52K
82570 <1% 9,204 $51K
27130 <1% 29 $51K
77334 <1% 2,151 $50K
76882 <1% 1,213 $50K
87529 <1% 761 $50K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 9,399 $49K
77301 <1% 303 $48K
90651 <1% 840 $48K
87088 <1% 6,806 $48K
77290 <1% 677 $47K
H2012 Behavioral health day treatment, per hour <1% 609 $46K
71045 Radiologic examination, chest; single view <1% 96,403 $46K
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units <1% 670 $46K
97016 <1% 2,820 $46K
85014 <1% 18,728 $45K
86592 <1% 7,805 $45K
90670 <1% 1,037 $45K
96112 <1% 158 $45K
86706 <1% 4,794 $45K
73130 <1% 11,617 $44K
27096 <1% 191 $44K
64615 <1% 463 $44K
29515 <1% 1,051 $43K
97803 <1% 2,090 $43K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) <1% 1,366 $43K
95913 <1% 688 $41K
73630 <1% 11,614 $41K
84100 <1% 13,021 $40K
92526 <1% 1,781 $40K
95910 <1% 615 $40K
84439 <1% 4,909 $40K
86704 <1% 3,668 $40K
82378 <1% 2,972 $39K
90680 <1% 1,350 $39K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 7,225 $38K
76937 <1% 4,612 $38K
84112 <1% 427 $37K
87497 <1% 1,392 $36K
84153 <1% 2,897 $36K
90648 <1% 1,637 $36K
82247 <1% 800 $36K
51705 <1% 536 $35K
74230 <1% 763 $35K
74178 <1% 479 $35K
87507 <1% 102 $35K
41899 Unlisted procedure, dentoalveolar structures <1% 87 $35K
94010 <1% 1,740 $34K
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg <1% 93 $34K
86334 <1% 2,779 $33K
86923 <1% 3,201 $33K
73502 <1% 6,609 $33K
J9263 Injection, oxaliplatin, 0.5 mg <1% 1,757 $33K
87075 <1% 4,979 $32K
93653 <1% 14 $32K
75561 <1% 314 $32K
72050 <1% 1,261 $31K
29827 <1% 27 $31K
J3471 Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) <1% 1,125 $31K
73700 <1% 839 $31K
80164 <1% 2,803 $31K
87799 <1% 1,093 $31K
63650 <1% 25 $30K
73610 <1% 9,854 $30K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 503 $29K
82075 <1% 1,040 $29K
82140 <1% 2,765 $29K
J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg <1% 101 $29K
82043 <1% 3,651 $29K
80074 <1% 678 $28K
87205 <1% 9,232 $28K
J2357 Injection, omalizumab, 5 mg <1% 138 $28K
90732 <1% 1,256 $27K
96523 <1% 1,351 $27K
43264 <1% 42 $27K
87493 <1% 999 $27K
86038 <1% 2,422 $27K
92611 <1% 554 $26K
62321 <1% 214 $26K
93880 <1% 745 $26K
90746 <1% 1,311 $26K
95874 <1% 990 $26K
97012 <1% 1,422 $26K
90677 <1% 2,352 $25K
84481 <1% 2,137 $25K
86762 <1% 2,089 $25K
84550 <1% 6,760 $25K
72146 <1% 411 $25K
72156 <1% 248 $24K
72158 <1% 315 $24K
83520 <1% 1,439 $24K
36592 <1% 2,273 $24K
Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg <1% 14 $23K
80177 <1% 1,926 $23K
96375 Therapeutic injection; each additional sequential IV push <1% 87,378 $23K
84165 <1% 3,789 $23K
93312 <1% 277 $23K
J9306 Injection, pertuzumab, 1 mg <1% 33 $23K
85046 <1% 6,207 $22K
90674 <1% 630 $22K
85652 <1% 10,856 $22K
87517 <1% 571 $22K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 453 $22K
78306 <1% 285 $22K
86300 <1% 1,899 $21K
84156 <1% 6,686 $21K
72131 <1% 622 $21K
86787 <1% 2,689 $21K
73110 <1% 6,188 $21K
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj <1% 44 $21K
88307 <1% 3,517 $21K
20611 <1% 139 $20K
59025 Fetal non-stress test <1% 273 $20K
82375 <1% 774 $19K
86235 <1% 151 $19K
P9045 Infusion, albumin (human), 5%, 250 ml <1% 171 $18K
72070 <1% 3,445 $18K
97167 <1% 588 $18K
91200 <1% 2,159 $17K
90716 <1% 479 $17K
88185 <1% 1,119 $17K
86301 <1% 1,103 $17K
93320 <1% 196 $17K
82805 <1% 451 $17K
73140 <1% 4,282 $17K
93922 <1% 585 $17K
83516 <1% 980 $17K
77001 <1% 1,265 $17K
12013 <1% 189 $16K
85347 <1% 2,223 $16K
90633 <1% 870 $16K
G0277 Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval <1% 114 $16K
78830 <1% 113 $16K
93925 <1% 485 $16K
77387 <1% 1,784 $15K
36591 <1% 2,351 $15K
84146 <1% 825 $15K
83655 <1% 949 $15K
90472 Immunization administration, each additional vaccine (list separately) <1% 2,259 $15K
83521 <1% 1,243 $15K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 313 $14K
96402 <1% 3,028 $14K
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram <1% 680 $14K
V5266 Battery for use in hearing device <1% 1,314 $14K
87902 <1% 67 $13K
82670 <1% 499 $13K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,155 $13K
38222 <1% 69 $13K
92557 <1% 365 $13K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg <1% 412 $13K
83883 <1% 932 $12K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 310 $12K
J2997 Injection, alteplase recombinant, 1 mg <1% 509 $12K
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg <1% 68 $12K
73080 <1% 3,618 $12K
77338 <1% 289 $12K
76775 <1% 413 $12K
64721 <1% 57 $12K
29105 <1% 134 $11K
94644 <1% 1,999 $11K
87102 <1% 1,460 $11K
82950 <1% 1,468 $11K
88360 <1% 1,501 $11K
83020 <1% 1,642 $11K
75716 <1% 31 $11K
94621 <1% 243 $11K
97802 <1% 550 $11K
75565 <1% 194 $11K
97018 <1% 947 $11K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 21,830 $11K
87015 <1% 2,408 $10K
87147 <1% 1,888 $10K
58301 <1% 74 $9K
J9041 Injection, bortezomib, 0.1 mg <1% 60 $9K
90739 <1% 447 $9K
73560 <1% 1,749 $9K
A9609 Fludeoxyglucose f18 up to 15 millicuries <1% 173 $9K
J9171 Injection, docetaxel, 1 mg <1% 190 $9K
90750 <1% 1,146 $9K
87449 <1% 974 $9K
83001 <1% 483 $9K
90723 <1% 1,606 $9K
86708 <1% 804 $9K
86147 <1% 476 $9K
43249 <1% 70 $9K
93296 <1% 1,779 $9K
J3489 Injection, zoledronic acid, 1 mg <1% 1,020 $8K
84403 <1% 402 $8K
90656 <1% 1,015 $8K
64490 <1% 39 $8K
88184 <1% 1,126 $8K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 206 $8K
36821 <1% 14 $8K
97542 <1% 524 $8K
J7030 Infusion, normal saline solution , 1000 cc <1% 136,015 $8K
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg <1% 18 $8K
36415 Collection of venous blood by venipuncture <1% 73,539 $8K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 225 $8K
58300 <1% 146 $8K
86160 <1% 385 $8K
J9173 Injection, durvalumab, 10 mg <1% 39 $8K
82103 <1% 571 $8K
85018 <1% 3,412 $7K
62369 <1% 151 $7K
90662 <1% 708 $7K
A6196 Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing <1% 4,549 $7K
73090 <1% 3,196 $7K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 86 $7K
J2785 Injection, regadenoson, 0.1 mg <1% 3,881 $7K
J9070 Cyclophosphamide, 100 mg <1% 318 $7K
64644 <1% 158 $7K
82150 <1% 652 $7K
82010 <1% 1,065 $7K
73590 <1% 4,558 $7K
93299 <1% 138 $7K
76942 <1% 1,628 $7K
86780 <1% 655 $7K
95912 <1% 124 $6K
97605 <1% 112 $6K
41800 <1% 83 $6K
86308 <1% 750 $6K
88344 <1% 1,463 $6K
76376 <1% 5,362 $6K
85461 <1% 744 $6K
80185 <1% 538 $6K
10005 <1% 39 $6K
90734 <1% 163 $6K
86920 <1% 1,173 $6K
71101 <1% 3,263 $6K
77049 <1% 48 $6K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 1,133 $5K
70487 <1% 58 $5K
73660 <1% 1,308 $5K
74022 <1% 3,347 $5K
78580 <1% 31 $5K
86870 <1% 584 $5K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 156 $5K
74181 <1% 45 $5K
82271 <1% 1,231 $5K
96401 <1% 1,526 $5K
80329 <1% 1,176 $5K
78264 <1% 59 $5K
64643 <1% 68 $5K
86304 <1% 453 $5K
86431 <1% 894 $5K
82248 <1% 1,140 $5K
C1874 Stent, coated/covered, with delivery system <1% 713 $5K
85613 <1% 453 $5K
87116 <1% 601 $5K
72170 <1% 2,264 $5K
83037 <1% 961 $5K
97022 <1% 254 $4K
93926 <1% 180 $4K
86200 <1% 408 $4K
85576 <1% 109 $4K
96409 <1% 1,623 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 74,859 $4K
87899 <1% 234 $4K
74019 <1% 800 $4K
73060 <1% 1,993 $4K
73552 <1% 2,181 $4K
82104 <1% 329 $4K
95909 <1% 49 $4K
84295 <1% 829 $4K
87045 <1% 423 $4K
88142 <1% 192 $4K
86225 <1% 335 $4K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit <1% 25 $4K
31720 <1% 260 $4K
88237 <1% 83 $4K
J7120 Ringers lactate infusion, up to 1000 cc <1% 62,415 $3K
82977 <1% 557 $3K
Q0243 Injection, casirivimab and imdevimab, 2400 mg <1% 179 $3K
G0379 Direct admission of patient for hospital observation care <1% 808 $3K
31231 <1% 71 $3K
84425 <1% 190 $3K
73564 <1% 1,195 $3K
64491 <1% 16 $3K
31624 <1% 25 $3K
87521 Neg quan hep c or qual rna <1% 115 $3K
77280 <1% 41 $3K
90700 <1% 458 $3K
83010 <1% 407 $3K
87427 <1% 341 $3K
A6197 Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing <1% 1,606 $3K
94625 <1% 395 $3K
36902 <1% 14 $3K
82947 <1% 830 $3K
84300 <1% 936 $3K
86665 <1% 133 $3K
75574 <1% 31 $3K
86015 <1% 275 $3K
80050 General health panel <1% 2,386 $3K
72120 <1% 132 $3K
82533 <1% 201 $3K
88112 <1% 727 $3K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 9,427 $3K
C1729 Catheter, drainage <1% 2,984 $3K
90707 <1% 458 $3K
J1610 Injection, glucagon hydrochloride, per 1 mg <1% 66 $3K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 84 $3K
72082 <1% 76 $3K
51702 <1% 779 $3K
85390 <1% 455 $3K
83013 <1% 42 $3K
77012 <1% 271 $3K
J9395 Injection, fulvestrant, 25 mg <1% 40 $3K
64495 <1% 20 $3K
72157 <1% 27 $2K
Q0114 Fern test <1% 346 $2K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 9,183 $2K
86146 <1% 123 $2K
86381 <1% 261 $2K
77295 <1% 13 $2K
29826 <1% 13 $2K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies <1% 17 $2K
86922 <1% 647 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 30,458 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 78,234 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 34,102 $2K
81002 <1% 94 $2K
J3370 Injection, vancomycin hcl, 500 mg <1% 10,742 $2K
36593 <1% 40 $2K
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg <1% 625 $2K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 1,390 $2K
88304 <1% 4,053 $2K
J7050 Infusion, normal saline solution, 250 cc <1% 72,523 $2K
86364 <1% 192 $2K
57454 <1% 14 $2K
36589 <1% 29 $2K
C1769 Guide wire <1% 14,849 $2K
87206 <1% 510 $2K
86705 <1% 250 $2K
J1644 Injection, heparin sodium, per 1000 units <1% 35,740 $2K
96376 <1% 31,852 $2K
95700 <1% 29 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 58,618 $2K
87350 <1% 155 $2K
87176 <1% 379 $2K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 3,805 $2K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 2,131 $2K
J2791 Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu <1% 25 $2K
90696 <1% 72 $2K
36600 <1% 415 $2K
86709 <1% 156 $1K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 684 $1K
80175 <1% 95 $1K
70549 <1% 13 $1K
87076 <1% 179 $1K
78227 <1% 13 $1K
84157 <1% 443 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 19,822 $1K
97129 <1% 138 $1K
82951 <1% 24 $1K
86769 <1% 29 $1K
87536 <1% 13 $1K
51798 <1% 2,804 $1K
A4648 Tissue marker, implantable, any type, each <1% 2,097 $1K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 4,550 $1K
84134 <1% 201 $1K
72220 <1% 360 $1K
70490 <1% 36 $1K
C1760 Closure device, vascular (implantable/insertable) <1% 1,217 $1K
92567 <1% 35 $1K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 41 $1K
72193 <1% 14 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 40,908 $1K
73120 <1% 219 $1K
83498 <1% 54 $1K
95012 <1% 167 $1K
73100 <1% 334 $1K
J3475 Injection, magnesium sulfate, per 500 mg <1% 17,287 $1K
87046 <1% 488 $1K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 9,477 $1K
82272 <1% 303 $1K
99245 <1% 13 $1K
84155 <1% 315 $1K
82945 <1% 227 $1K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 36,914 $1K
92083 <1% 387 $1K
93976 <1% 29 $1K
A6212 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing <1% 4,095 $990.82
82365 <1% 44 $986.92
93282 <1% 173 $969.57
G0260 Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography <1% 27 $957.79
73620 <1% 223 $954.19
88342 <1% 2,893 $952.22
74160 <1% 12 $948.44
90678 <1% 66 $935.71
82668 <1% 87 $907.94
82390 <1% 102 $902.70
85732 <1% 149 $897.43
J2704 Injection, propofol, 10 mg <1% 57,944 $879.90
56405 <1% 13 $862.60
90480 <1% 26 $857.85
90381 <1% 18 $852.18
87480 <1% 42 $843.31
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 32,508 $842.06
J9190 Injection, fluorouracil, 500 mg <1% 3,761 $839.73
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 6,428 $829.48
94150 <1% 1,378 $829.37
95911 <1% 26 $827.80
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 391 $821.95
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 4,311 $817.39
J1815 Injection, insulin, per 5 units <1% 41,644 $812.88
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 12 $809.21
87510 <1% 42 $781.15
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 26,062 $767.59
0031A <1% 22 $754.05
77399 <1% 54 $750.91
J1170 Injection, hydromorphone, up to 4 mg <1% 33,617 $746.93
82627 <1% 12 $744.75
87154 <1% 87 $730.95
86707 <1% 70 $723.92
J9206 Injection, irinotecan, 20 mg <1% 98 $723.44
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 2,058 $717.28
85049 <1% 24 $710.79
A6222 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 3,157 $699.13
70360 <1% 337 $691.44
C1747 Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable) <1% 63 $667.08
99205 Prolong outpt/office vis <1% 15 $643.91
83930 <1% 144 $639.55
J1456 Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg <1% 29 $632.28
73521 <1% 73 $628.76
90710 <1% 94 $626.28
Q0239 Injection, bamlanivimab-xxxx, 700 mg <1% 24 $601.48
86593 <1% 155 $589.32
Q0247 Injection, sotrovimab, 500 mg <1% 22 $579.04
80178 <1% 111 $578.08
80320 <1% 4,203 $568.48
95712 <1% 15 $554.61
96381 <1% 56 $551.21
96411 <1% 3,440 $544.89
85384 <1% 59 $539.21
88173 <1% 1,012 $530.56
G0008 Administration of influenza virus vaccine <1% 1,214 $522.66
97130 <1% 24 $506.58
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 18 $493.06
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 40,979 $489.76
J0690 Injection, cefazolin sodium, 500 mg <1% 21,500 $482.16
74220 <1% 28 $479.03
99443 <1% 33 $469.18
95992 <1% 23 $457.48
90380 <1% 35 $426.09
86039 <1% 40 $383.25
88271 <1% 13 $375.24
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 2,329 $367.19
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 756 $363.43
36410 <1% 17 $362.66
92133 <1% 410 $349.05
A6021 Collagen dressing, sterile, size 16 sq. in. or less, each <1% 1,775 $346.17
73600 <1% 26 $340.07
73070 <1% 58 $338.94
98966 <1% 20 $338.85
84166 <1% 27 $337.20
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel <1% 16 $322.76
86361 <1% 12 $316.82
72072 <1% 136 $309.85
83789 <1% 16 $300.33
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 6,756 $300.05
76819 Fetal biophysical profile; without non-stress testing <1% 14 $297.94
A9585 Injection, gadobutrol, 0.1 ml <1% 13,104 $291.51
J0360 Injection, hydralazine hcl, up to 20 mg <1% 10,959 $285.59
84450 <1% 55 $272.13
0124A <1% 12 $270.94
86644 <1% 17 $266.94
88313 <1% 1,072 $258.34
36247 <1% 19 $242.27
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 3,504 $237.83
36416 <1% 8,907 $227.56
A4565 Slings <1% 4,695 $223.94
88333 <1% 463 $212.16
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 94 $205.41
C9113 Injection, pantoprazole sodium, per vial <1% 9,715 $205.02
80202 <1% 21 $186.91
94727 <1% 70 $186.05
69200 <1% 14 $180.00
J0461 Injection, atropine sulfate, 0.01 mg <1% 1,327 $164.36
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 4,378 $163.58
C1781 Mesh (implantable) <1% 1,045 $154.63
81050 <1% 46 $153.63
A4212 Non-coring needle or stylet with or without catheter <1% 13,180 $149.38
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 29,021 $147.27
86902 <1% 18 $141.77
87807 <1% 13 $141.49
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 3,377 $140.12
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 129 $133.93
A6248 Hydrogel dressing, wound filler, gel, per fluid ounce <1% 925 $132.72
73523 <1% 12 $132.40
71100 <1% 17 $123.03
L3908 Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf <1% 24 $116.09
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 4,744 $115.19
83921 <1% 13 $111.35
82232 <1% 14 $110.19
80162 <1% 16 $109.76
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 2,171 $108.84
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc <1% 955 $106.36
A9270 Non-covered item or service <1% 41,995 $101.90
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 2,082 $96.95
99152 <1% 3,389 $93.14
82042 <1% 15 $92.97
86880 <1% 18 $90.80
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals <1% 272 $89.74
J1650 Injection, enoxaparin sodium, 10 mg <1% 37,203 $86.35
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 22,773 $77.26
85670 <1% 414 $75.29
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 4,658 $73.88
97810 <1% 30 $72.87
88302 <1% 489 $71.72
88312 <1% 1,272 $71.07
93041 <1% 640 $70.76
90713 <1% 14 $66.25
J0780 Injection, prochlorperazine, up to 10 mg <1% 6,753 $65.45
70355 <1% 16 $57.65
J2060 Injection, lorazepam, 2 mg <1% 15,482 $55.09
J1940 Injection, furosemide, up to 20 mg <1% 9,189 $54.94
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 2,630 $54.42
93280 <1% 25 $49.53
83050 <1% 14 $46.55
J7999 Compounded drug, not otherwise classified <1% 2,313 $43.40
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 4,621 $38.30
73000 <1% 12 $37.48
88311 <1% 610 $36.52
97811 <1% 29 $33.59
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 4,212 $30.27
92060 <1% 52 $26.93
J3480 Injection, potassium chloride, per 2 meq <1% 11,902 $25.65
J0692 Injection, cefepime hydrochloride, 500 mg <1% 7,105 $24.11
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 689 $22.97
93225 <1% 15 $22.38
A6209 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 787 $21.52
C1758 Catheter, ureteral <1% 2,299 $18.57
99153 Mod sedat endo service >5yrs <1% 1,253 $18.49
J1596 Injection, glycopyrrolate, 0.1 mg <1% 713 $15.46
J1630 Injection, haloperidol, up to 5 mg <1% 6,025 $13.56
88341 <1% 50 $12.86
J3590 Unclassified biologics <1% 2,827 $11.99
J1956 Injection, levofloxacin, 250 mg <1% 1,520 $10.66
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 1,306 $10.50
J1626 Injection, granisetron hydrochloride, 100 mcg <1% 1,325 $10.44
J1790 Injection, droperidol, up to 5 mg <1% 1,459 $8.90
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 3,180 $8.62
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 152 $7.64
J9045 Injection, carboplatin, 50 mg <1% 2,853 $6.66
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 413 $6.42
J0640 Injection, leucovorin calcium, per 50 mg <1% 1,682 $6.13
J3411 Injection, thiamine hcl, 100 mg <1% 2,570 $5.58
J0456 Injection, azithromycin, 500 mg <1% 2,160 $5.58
J1250 Injection, dobutamine hydrochloride, per 250 mg <1% 1,083 $5.18
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,189 $3.38
A4467 Belt, strap, sleeve, garment, or covering, any type <1% 296 $2.04
J0610 Injection, calcium gluconate (fresenius kabi), per 10 ml <1% 17 $1.83
A6207 Contact layer, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing <1% 1,004 $1.70
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 5,092 $1.00
J1040 Injection, methylprednisolone acetate, 80 mg <1% 438 $0.79
J1030 Injection, methylprednisolone acetate, 40 mg <1% 621 $0.76
C2625 Stent, non-coronary, temporary, with delivery system <1% 819 $0.46
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 1,225 $0.44
91312 <1% 13 $0.03
91303 <1% 22 $0.01
A6206 Contact layer, sterile, 16 sq. in. or less, each dressing 0% 1,962 $0.00
J1050 Injection, medroxyprogesterone acetate, 1 mg 0% 3,718 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 342 $0.00
J7510 Prednisolone oral, per 5 mg 0% 1,377 $0.00
G8996 Swallowing functional limitation, current status at therapy episode outset and at reporting intervals 0% 223 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 2,126 $0.00
A6210 Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing 0% 625 $0.00
J1580 Injection, garamycin, gentamicin, up to 80 mg 0% 766 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 1,025 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 1,814 $0.00
J9060 Injection, cisplatin, powder or solution, 10 mg 0% 506 $0.00
C1776 Joint device (implantable) 0% 1,119 $0.00
A6010 Collagen based wound filler, dry form, sterile, per gram of collagen 0% 197 $0.00
J3250 Injection, trimethobenzamide hcl, up to 200 mg 0% 134 $0.00
G8989 Self care functional limitation, discharge status, at discharge from therapy or to end reporting 0% 159 $0.00
A6403 Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing 0% 1,023 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 2,117 $0.00
J9000 Injection, doxorubicin hydrochloride, 10 mg 0% 334 $0.00
C1788 Port, indwelling (implantable) 0% 168 $0.00
J3473 Injection, hyaluronidase, recombinant, 1 usp unit 0% 73 $0.00
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 0% 200 $0.00
G8997 Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 234 $0.00
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries 0% 68 $0.00
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries 0% 46 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 447 $0.00
J2720 Injection, protamine sulfate, per 10 mg 0% 62 $0.00
C1876 Stent, non-coated/non-covered, with delivery system 0% 31 $0.00
J7070 Infusion, d5w, 1000 cc 0% 38 $0.00
J0736 Injection, clindamycin phosphate, 300 mg 0% 16 $0.00
69210 0% 12 $0.00
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 0% 43 $0.00
J1800 Injection, propranolol hcl, up to 1 mg 0% 14 $0.00
J3415 Injection, pyridoxine hcl, 100 mg 0% 27 $0.00
92978 0% 13 $0.00
82610 0% 13 $0.00
V2632 Posterior chamber intraocular lens 0% 1,249 $0.00
J0574 Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine 0% 130 $0.00
C1726 Catheter, balloon dilatation, non-vascular 0% 844 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 625 $0.00
J9267 Injection, paclitaxel, 1 mg 0% 2,920 $0.00
A9540 Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries 0% 1,610 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 3,519 $0.00
J7042 5% dextrose/normal saline (500 ml = 1 unit) 0% 289 $0.00
A9567 Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries 0% 1,067 $0.00
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 0% 3,344 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 0% 317 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 434 $0.00
G8982 Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 105 $0.00
J1805 Injection, esmolol hydrochloride, 10 mg 0% 386 $0.00
J1920 Injection, labetalol hydrochloride, 5 mg 0% 1,472 $0.00
88300 0% 18 $0.00
A6223 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing 0% 103 $0.00
C1730 Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) 0% 34 $0.00
J2150 Injection, mannitol, 25% in 50 ml 0% 67 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 0% 611 $0.00
A4364 Adhesive, liquid or equal, any type, per oz 0% 198 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 613 $0.00
C9290 Injection, bupivacaine liposome, 1 mg 0% 186 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 454 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 0% 304 $0.00
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml 0% 125 $0.00
G8981 Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals 0% 44 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 669 $0.00
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg 0% 55 $0.00
G8998 Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting 0% 56 $0.00
C1778 Lead, neurostimulator (implantable) 0% 14 $0.00
J0613 Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg 0% 99 $0.00
76377 0% 28 $0.00
J9181 Injection, etoposide, 10 mg 0% 50 $0.00
C2623 Catheter, transluminal angioplasty, drug-coated, non-laser 0% 58 $0.00
C1892 Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away 0% 83 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 551 $0.00
J0173 Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg 0% 184 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 78 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 103 $0.00
88331 0% 28 $0.00
C2618 Probe/needle, cryoablation 0% 28 $0.00
J3410 Injection, hydroxyzine hcl, up to 25 mg 0% 25 $0.00
G0010 Administration of hepatitis b vaccine 0% 34 $0.00
A6022 Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each 0% 94 $0.00
J0697 Injection, sterile cefuroxime sodium, per 750 mg 0% 36 $0.00
L0150 Cervical, semi-rigid, adjustable molded chin cup (plastic collar with mandibular/occipital piece) 0% 28 $0.00
C9399 Unclassified drugs or biologicals 0% 366 $0.00
87593 0% 34 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 51 $0.00
J1270 Injection, doxercalciferol, 1 mcg 0% 17 $0.00
88334 0% 18 $0.00
J7507 Tacrolimus, immediate release, oral, 1 mg 0% 76 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRICHARDSON, KARA (VP MANAGED HEALTH)
Same official

Other billing entities under RICHARDSON, KARA

Full network →
ProviderLocationPaid
A2cl Services, LLCWest Allis, WI$98.74M
Aurora Psychiatric Hospital, INC.Wauwatosa, WI$28.09M
Baycare Aurora, LLCGreen Bay, WI$25.37M
West Allis Memorial Hospital, INC.West Allis, WI$23.29M
Aurora Medical Center of Oshkosh, INCOshkosh, WI$16.47M
Visiting Nurse Association of Wisconsin, INC.West Allis, WI$15.36M
Aurora Health Care Central, INC.Sheboygan, WI$12.39M
Visiting Nurse Association of Wisconsin, INC.Wauwatosa, WI$9.78M
Aurora Medical Center Bay Area, INCMarinette, WI$9.68M
Lakeshore Medical Clinic, LLCSaint Francis, WI$8.38M
Ehs Home Health Care Service INCOak Brook, IL$7.28M
Aurora Health Care North, INC.Two Rivers, WI$6.80M
Advocate Home Care Products INCDowners Grove, IL$5.39M
Aurora Health Care Southern Lakes, INC.Burlington, WI$5.25M
Advocate Health and Hospitals CorporationPark Ridge, IL$3.89M
Aurora Medical Center of Washington County, INC.Hartford, WI$3.25M
Advocate Home Care Products, INCBridgeview, IL$2.37M
Advocate Health and Hospitals CorporationOak Lawn, IL$2.31M
Aurora Medical Center Bay Area, INCMarinette, WI$1.55M
Advocate North Side Health NetworkChicago, IL$1.19M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.